 And a lot of the supply chain issues, I think, in the health care and the biotechnology pharma space, Joy, sort of stem from lessons learned from COVID. Is that fair, just kind of to level set things? I think so. Yeah, that's where some of the supply chain challenges really came into focus, right, during the pandemic, though they were there.